Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

e-NIOS

e-NIOS
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$88.3K LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of a data analysis and interpretation platform designed to offer differential expression analysis with pathway and gene prioritization. The company's platform provides a tool for molecular experiments, in order to contribute to the elucidation of complex biological mechanisms and to deliver novel molecular markers or targets for diagnostics and therapeutics, enabling clients to reduce biological complexity and transform raw data into robust biomarker signatures.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • Al. Pantou 25
  • Kallithea
  • Athens, 176 71
  • Greece

+30 21 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore e-NIOS’s full profile, request a free trial.

e-NIOS Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round $88.3K 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

e-NIOS Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mammoth Biosciences Venture Capital-Backed San Francisco, CA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Menlo Park, CA 0 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

e-NIOS Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
IQbility Accelerator/Incubator Minority 000 0000 000000 0
PJ Tech Catalyst Venture Capital Minority 000 0000 000000 0

e-NIOS Executive Team (3)

Name Title Board
Seat
Contact
Info
Aristotelis Chatziioannou Ph.D Chief Executive Officer & Co-Founder
Eleftherios Pilalis Ph.D Co-Founder

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »